| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CDT Equity Inc. | Director | Common Stock | 37,369 | $70,253 | $1.88 | 12 Aug 2025 | Direct |
| CDT Equity Inc. | Director | Stock Option (Right to Buy) | 15,000 | $29,820 | $0.0710 | 05 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000114036125044059-farley-chele-chiavacci-2025-12-02 | General Purpose Acquisition Corp. | 02 Dec 2025 | 0 | $0 | 3 | Director | 02 Dec 2025, 18:41 |
| CDT | CDT Equity Inc. | 05 Aug 2025 | 2 | $0 | 4 | Director | 26 Aug 2025, 16:30 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 30 Mar 2025 | 1 | +$28,500 | 4 | Director | 01 Apr 2025, 21:07 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 18 Dec 2024 | 1 | +$29,820 | 4 | Director | 20 Dec 2024, 17:06 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 18 Nov 2024 | 1 | +$27,500 | 4 | Director | 20 Nov 2024, 16:30 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 11 Jun 2024 | 1 | $0 | 4 | Director | 11 Jun 2024, 17:56 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 22 Apr 2024 | 2 | $0 | 4 | Director | 24 Apr 2024, 17:00 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 01 Dec 2023 | 1 | +$358,150 | 4 | Director | 05 Dec 2023, 17:20 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 22 Sep 2023 | 2 | +$172,500 | 4 | Director | 26 Sep 2023, 17:49 |
| CDT | Murphy Canyon Acquisition Corp. | 02 Feb 2022 | 0 | $0 | 3 | Director | 11 Feb 2022, 15:31 |